Crossmark

TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma

Crossref DOI link: https://doi.org/10.1038/s41379-021-00848-0

Published Print: 2021-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Zhang, Yifan https://orcid.org/0000-0001-8525-4736
Chen, Yi https://orcid.org/0000-0002-4891-8289
Yang, Chen

Seger, Nelly

Hesla, Asle C. https://orcid.org/0000-0001-6205-0773
Tsagkozis, Panagiotis

Larsson, Olle

Lin, Yingbo

Haglund, Felix https://orcid.org/0000-0002-7015-3841
Funding

Funding for this research was provided by:

Stiftelsen Tornspiran (201809)

Karolinska Institutet

Cancerfonden (JCIA-190003, PJ-190299)

Cancerföreningen i Stockholm (184053)
License Information

Text and Data Mining valid from 2021-11-01

Text and Data Mining valid from 2021-11-01

Version of Record valid from 2023-01-05
More Information

This article is maintained by: Elsevier

Article Title: TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma

Journal Title: Modern Pathology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1038/s41379-021-00848-0

Content Type: article

Copyright: © 2021 The Authors.